WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005

Feb 8, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2004-05-26

Reporting Person: HARGESHEIMER ROBERT S (Div Pres-Pharma Device Group)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-05-26	Common Stock	M	800	$26.0300	Acquired	7819.8238	Direct
2004-05-26	Common Stock	S	800	$38.0650	Disposed	7019.8238	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-05-26	Stock Option (Right to Buy)	$26.0300	M	800	Disposed	2005-03-25	Common Stock (800.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1860.6248	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.